| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| afrodisiakum |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Tranquilizer |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anti-psychotic agent (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antidepressant (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytic, sedative AND/OR hypnotic (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sedativum/neurolepticum |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| anxiolytikum, sedativum OG/ELLER hypnotikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| antipsykotisk middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing tryptophan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| hypnotika |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Remoxipride hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antipsychotic depot injections |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 520mg/5mL sugar free liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| lithiumcarbonat 200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| lithiumcarbonat 450 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| lithiumcarbonat 400 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| lithiumcitrat 520 mg/5 ml sukkerfri oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium citrate 203.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Viloxazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| antidepressiva, kombinationsmidler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| fluphenazinhydrochlorid 500 µg + nortriptylin 10 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| amitriptylinhydrochlorid 25 mg + perphenazin 2 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| amitriptylinhydrochlorid 10 mg + perphenazin 2 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Other antidepressant drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 200 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytics and neuroleptic perioperative drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 15 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 30 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing viloxazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing remoxipride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| ikke-barbiturat-hypnotikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| antidepressivum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| psykofarmakon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium carbonate 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate cr 450mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 65 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 130 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| paraldehyd til parenteral anvendelse, injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phenobarbital 20 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| lithiumcarbonat tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithotab 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing paraldehyde in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| paraldehyd rektalvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Amitriptyline hydrochloride+perphenazine 10mg/4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| amitriptylinhydrochlorid 25 mg + perphenazin 4 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| amitriptylinhydrochlorid 50 mg + perphenazin 4 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing triazolopyridine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Oral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Parenteral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Ergoloid mesylate |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| barbiturathypnotikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sodium oxybate 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| psykoterapeutisk middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antimanic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| anxiolytikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 520mg/5mL sugar free liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sodium oxybate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium citrate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Dihydroergotamine mesilate |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| stemningsstabiliserende middel |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
FHIR